Ming‐Yang Lee

1.4k total citations
43 papers, 975 citations indexed

About

Ming‐Yang Lee is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Ming‐Yang Lee has authored 43 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Surgery and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Ming‐Yang Lee's work include Circadian rhythm and melatonin (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Spinal Fractures and Fixation Techniques (3 papers). Ming‐Yang Lee is often cited by papers focused on Circadian rhythm and melatonin (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Spinal Fractures and Fixation Techniques (3 papers). Ming‐Yang Lee collaborates with scholars based in Taiwan, United States and France. Ming‐Yang Lee's co-authors include Tian‐Shung Wu, Tsung‐Ying Chen, E‐Jian Lee, Hung‐Yi Chen, Guan‐Liang Chang, E-Jian Lee, Hannah J. Joyce, Laura M. Herz, Ming‐Hui Chiu and Chang‐Hsiao Chen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and ACS Nano.

In The Last Decade

Ming‐Yang Lee

39 papers receiving 954 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming‐Yang Lee Taiwan 14 242 159 155 148 140 43 975
Tuomas O. Lilius Finland 21 190 0.8× 163 1.0× 35 0.2× 113 0.8× 178 1.3× 49 1.6k
Zhihua Zhang China 18 143 0.6× 342 2.2× 85 0.5× 131 0.9× 16 0.1× 67 1.2k
Yaoming Chen China 20 70 0.3× 352 2.2× 64 0.4× 92 0.6× 50 0.4× 65 1.1k
Xiangming Liu China 19 101 0.4× 562 3.5× 46 0.3× 36 0.2× 79 0.6× 93 1.4k
Dan Li China 29 100 0.4× 725 4.6× 61 0.4× 116 0.8× 27 0.2× 129 2.0k
Akitoshi Seiyama Japan 19 47 0.2× 172 1.1× 170 1.1× 40 0.3× 39 0.3× 100 1.5k
Charles Weaver United States 10 51 0.2× 456 2.9× 154 1.0× 119 0.8× 51 0.4× 20 1.2k
Paul D. Crane United States 19 46 0.2× 323 2.0× 59 0.4× 61 0.4× 38 0.3× 39 1.6k
Yuki Hirota Japan 21 332 1.4× 669 4.2× 99 0.6× 226 1.5× 21 0.1× 54 2.1k
Ai-Ling Lin United States 23 87 0.4× 682 4.3× 130 0.8× 266 1.8× 46 0.3× 29 1.8k

Countries citing papers authored by Ming‐Yang Lee

Since Specialization
Citations

This map shows the geographic impact of Ming‐Yang Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Yang Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Yang Lee more than expected).

Fields of papers citing papers by Ming‐Yang Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Yang Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Yang Lee. The network helps show where Ming‐Yang Lee may publish in the future.

Co-authorship network of co-authors of Ming‐Yang Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Yang Lee. A scholar is included among the top collaborators of Ming‐Yang Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Yang Lee. Ming‐Yang Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shen, Cheng-Huang, Jinyi Wu, Haibo Liu, et al.. (2025). Enhanced tumor suppressive effect of a new HDAC inhibitor in bladder cancer in vitro and in vivo. Biomedicine & Pharmacotherapy. 187. 118108–118108.
3.
Chen, Tsung‐Hsien, et al.. (2025). Mitochondrial alterations and signatures in hepatocellular carcinoma. Cancer and Metastasis Reviews. 44(1). 34–34. 8 indexed citations
4.
5.
Lee, Yu‐Ting, Chi‐Wen Tu, Ming‐Yang Lee, et al.. (2022). Parathyroidectomy Improves the Consumption of Erythropoiesis-Stimulating Agents in Hemodialysis Patients. International Journal of Molecular Sciences. 23(18). 10391–10391. 1 indexed citations
6.
7.
Lee, Ming‐Yang, Chung‐Sheng Shi, Kao-Jean Huang, et al.. (2019). Honokiol Is a Potential Therapeutic Agent and Has a Synergistic Effect With 5-FU in Human Urothelial Cell Carcinoma Cells. Anticancer Research. 39(12). 6555–6565. 8 indexed citations
8.
Lee, Ming‐Yang, Yizhen Li, Kao-Jean Huang, et al.. (2018). Indirubin-3'-oxime suppresses human cholangiocarcinoma through cell-cycle arrest and apoptosis. European Journal of Pharmacology. 839. 57–65. 10 indexed citations
9.
10.
Lee, Ming‐Yang, et al.. (2013). Oxaliplatin-induced acquired long QT syndrome with torsades de pointes and myocardial injury in a patient with dilated cardiomyopathy and rectal cancer. Journal of the Chinese Medical Association. 76(8). 466–469. 9 indexed citations
11.
12.
Lee, Ming‐Yang, et al.. (2012). Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT. International Journal of Molecular Medicine. 30(5). 1021–1028. 57 indexed citations
13.
Huang, Dawei, et al.. (2009). A Rare Occipital Condyle Fracture in a Patient With A Minor Head Injury. The Kaohsiung Journal of Medical Sciences. 25(6). 342–346. 4 indexed citations
14.
Huang, Yung‐Cheng, et al.. (2009). Malignant Pleural Mesothelioma Presenting as Low Back Pain. Spine. 34(21). E780–E783. 6 indexed citations
15.
Hung, Yu‐Chang, Tsung‐Ying Chen, E‐Jian Lee, et al.. (2008). Melatonin decreases matrix metalloproteinase‐9 activation and expression and attenuates reperfusion‐induced hemorrhage following transient focal cerebral ischemia in rats. Journal of Pineal Research. 45(4). 459–467. 50 indexed citations
16.
Lee, Ming‐Yang, Yu‐Hsiang Kuan, Hung‐Yi Chen, et al.. (2007). Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats. Journal of Pineal Research. 42(3). 297–309. 122 indexed citations
17.
18.
Lee, E‐Jian, et al.. (2004). Melatonin attenuates gray and white matter damage in a mouse model of transient focal cerebral ischemia. Journal of Pineal Research. 38(1). 42–52. 104 indexed citations
19.
Chien, Chih-Chiang, et al.. (2004). Tuberculosis-Associated Hemophagocytic Syndrome in a Hemodialysis Patient with Protracted Fever. International Journal of Hematology. 79(4). 334–336. 9 indexed citations
20.
Lee, E‐Jian, et al.. (2003). Delayed treatment with melatonin enhances electrophysiological recovery following transient focal cerebral ischemia in rats. Journal of Pineal Research. 36(1). 33–42. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tuomas O. Lilius Breakdown of academic impact, for papers by Zhihua Zhang Breakdown of academic impact, for papers by Yaoming Chen Breakdown of academic impact, for papers by Xiangming Liu Breakdown of academic impact, for papers by Dan Li Breakdown of academic impact, for papers by Akitoshi Seiyama Breakdown of academic impact, for papers by Charles Weaver Breakdown of academic impact, for papers by Paul D. Crane Breakdown of academic impact, for papers by Yuki Hirota Breakdown of academic impact, for papers by Ai-Ling Lin
Rankless by CCL
2026